SiBreaX develops drugs based on targeted drug delivery via a unique delivery system. For the first time, SiBreaX technology of triggered-breakable silicate nanoparticles opens access to the efficient delivery of peptides and proteins into target cells. With our technology, we access the targeted delivery of drugs to treat lung, liver, and immune cell borne diseases.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology
- Website
- http://www.sibreax.com
- Keywords
- Zürich.
Sibreax Questions
Sibreax's website is http://www.sibreax.com
Sibreax's LinkedIn profile is https://ch.linkedin.com/company/sibreax
Sibreax has
1 employees.
View email and phone details for 1
employees at Sibreax.
Sibreax's industry is
Biotechnology
Sibreax's top competitors are
Curadigm,
Lamina Therapeutics,
Era Nutrition Gmbh,
Serendip Innovations,
Syndivia,
Innomedica Holding Ag,
Ferropharma Group,
Renzo Balboa Ag,
Alphaonco,
Mecaura.
Sibreax's categories are Biotechnology
Sibreax's founding year is 2017
